An update on biomarkers of bone turnover and their utility in biomedical research and clinical practice D. J. LeemingP. AlexandersenL. B. Tankó Review Article 16 August 2006 Pages: 781 - 792
Current and novel approaches to the drug therapy of obesity Jean-Philippe ChaputAngelo Tremblay Review Article 26 August 2006 Pages: 793 - 803
Conventional and sustained-release valproate in children with newly diagnosed epilepsy: a randomized and crossover study comparing clinical effects, patient preference and pharmacokinetics José L. HerranzRosa ArteagaJuan A. Armijo Clinical Trials 02 August 2006 Pages: 805 - 815
Effects of amlodipine-atorvastatin combination on inflammation markers and insulin sensitivity in normocholesterolemic obese hypertensive patients Roberto FogariPaola PretiGiuseppe Derosa Clinical Trials 02 August 2006 Pages: 817 - 822
Prospective sonographic evaluation of fentanyl side effects on the neonatal gallbladder Beate SchmidtBernhard RothGabriele Benz-Bohm Pharmacodynamics 29 July 2006 Pages: 823 - 827
UGT1A polymorphisms in a Swedish cohort and a human diversity panel, and the relation to bilirubin plasma levels in males and females J. Mercke OdebergJ. AndradeJ. Odeberg Pharmacogenetics 15 August 2006 Pages: 829 - 837
Predicting brain concentrations of drug using positron emission tomography and venous input: modeling of arterial-venous concentration differences Stina SyvänenGunnar BlomquistMats Bergström Pharmacokinetics and Disposition 08 August 2006 Pages: 839 - 848
A comparative study of the pharmacokinetics of ibuprofen arginate versus dexibuprofen in healthy volunteers Belén SádabaMiguel A. CampaneroJose R. Azanza Pharmacokinetics and Disposition 15 August 2006 Pages: 849 - 854
Identification of the time-point which gives a plasma rabeprazole concentration that adequately reflects the area under the concentration-time curve Takenori NiiokaTsukasa UnoTomonori Tateishi Pharmacokinetics and Disposition 17 August 2006 Pages: 855 - 861
Prevalence and patterns of antidepressant drug use during pregnancy Tessa VerversHans KaasenbroodToine Egberts Pharmacoepidemiology and Prescription 08 August 2006 Pages: 863 - 870
Transport studies with 5-aminosalicylate Hua-Wen XinMatthias SchwabUlrich Klotz Short Communication 30 August 2006 Pages: 871 - 875
Effect of CYP2C19*17 gene variant on Helicobacter pylori eradication in peptic ulcer patients Mateusz KurzawskiBarbara Gawrońska-SzklarzMarek Droździk Short Communication 16 August 2006 Pages: 877 - 880
Multiple gene polymorphisms and warfarin sensitivity Eriko ShikataIchiro IeiriKenji Otsubo Letter to the Editors 04 July 2006 Pages: 881 - 883